We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Commission has announced that it expects to receive approximately 200 million doses of Pfizer/BioNTech’s two-dose COVID-19 vaccine in the second quarter, giving hope that the EU may reach its inoculation goals on time despite serious setbacks to vaccine deliveries. Read More
Nearly two dozen attorneys general (AG) have come out against a $10 billion bankruptcy proposal put forth by Purdue Pharma to settle thousands of opioid lawsuits, calling it an improvement over the original plan but still inadequate in the compensation it provides. Read More
France, Italy and Germany have become the latest European countries to halt inoculations with AstraZeneca’s COVID-19 vaccine after 37 cases of blood clots were reported, joining an increasing number of other member states in temporarily putting them on pause as a safety review is conducted. Read More
Fresh off the FDA’s March 1 authorization of Johnson & Johnson’s (J&J) single-shot vaccine, President Biden announced that the U.S. has secured an additional 100 million doses of the shot, doubling its original supply agreement with the company. Read More
Amgen has agreed to acquire Five Prime Therapeutics, a South San Francisco biotech company, for $1.9 billion, a deal that will net the biopharma titan a pipeline that includes a promising investigational gastric cancer drug. Read More
Germany’s CureVac has partnered with pharma giant Novartis to potentially manufacture hundreds of millions of doses of the small company’s COVID-19 vaccine candidate, CVnCoV, which is now under review by the European Medicines Agency (EMA). Read More
Perrigo is transforming itself into a “consumer self-care” business, according to Murray Kessler, president and CEO of the Dublin, Ireland-based company. Read More